The State Common Entrance Test Cell, Mumbai, has officially started the registration process for the MAH CET 2026 for ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Mumbai: With as many as 12 newly elected BMC corporators belonging to Gen Z—aged under 30—the new House is set to get a ...

With no new safety signals emerging in its phase 3 trials, Alumis plans to file for FDA approval in the back half of 2026. FDA approval could add to the pressure on Sotyktu, which generated $206 ...

The availability of a more affordable biosimilar is expected to improve access to advanced cancer treatment not just in major ...

The current state of radiotherapeutics is “the isotope wars”, according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

BRUNSWICK, Ohio -- The snow was kind of hiding Hinckley Lake, but my great-grandson and I headed over to see if it was ...

Your health should be your top priority at all times. It is the foundation for everything else that you do in life. You know ...

Many EV drivers unknowingly shorten their car's battery life. Learn which habits to unlearn if you want your electric vehicle to last longer.

Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...